Literature DB >> 26626209

Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.

Michael Michal1, Dmitry V Kazakov2, Ladislav Hadravský2, Abbas Agaimy3, Marián Švajdler4, Naoto Kuroda5, Michal Michal2.   

Abstract

We describe 9 cases of pleomorphic hyalinizing angiectatic tumor (PHAT). Recently described TGFBR3 and MGEA5 gene rearrangements in these tumors have confirmed the long-hypothesized link between PHAT and another soft tissue entity, the myxoinflammatory fibroblastic sarcoma (MIFS). Myxoinflammatory fibroblastic sarcoma and PHAT share the same translocation and in addition have a very similar clinical presentation. However, to our best knowledge, no study has ever addressed the striking morphologic similarities between MIFS and PHAT. Our findings based on histological criteria suggest that most, if not all, tumors diagnosed as PHAT might, in fact, represent examples of MIFS that, in addition to a conventional MIFS morphology, manifest aberrant angiectatic hyalinized vessels.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Myxoinflammatory fibroblastic sarcoma; Pleomorphic hyalinizing angiectatic tumor; Soft tissues

Mesh:

Substances:

Year:  2015        PMID: 26626209     DOI: 10.1016/j.anndiagpath.2015.10.006

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  3 in total

Review 1.  What's new in fibroblastic tumors?

Authors:  Susan M Armstrong; Elizabeth G Demicco
Journal:  Virchows Arch       Date:  2019-12-11       Impact factor: 4.064

2.  Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report.

Authors:  Renata Margarida Etchebehere; Elia Cláudia Souza Almeida; Carlos David Teixeira Santos; Adilha Misson Rua Micheletti; Antônio Sebastião Leitão
Journal:  Rev Bras Ortop       Date:  2016-11-16

3.  Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.

Authors:  David Suster; Michael Michal; Huiya Huang; Shira Ronen; Stephanie Springborn; Maria Debiec-Rychter; Steven D Billings; John R Goldblum; Brian P Rubin; Michal Michal; Saul Suster; A Craig Mackinnon
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.